glucosylceramide

Glucosylceramide, also called glucocerebroside, is a glycosphingolipid composed of a ceramide backbone attached to a single glucose molecule via a β-glycosidic bond. The ceramide consists of a sphingosine base amide-linked to a fatty acid. In cell membranes, GlcCer resides in the outer leaflet and participates in the organization of lipid domains.

Biosynthesis occurs in the Golgi and endoplasmic reticulum of cells, beginning with ceramide. Glucosyltransferase (glucosylceramide synthase, UGCG) transfers glucose from UDP-glucose to ceramide to yield GlcCer and UDP. GlcCer serves as a precursor for more complex glycosphingolipids such as lactosylceramide and gangliosides.

Degradation occurs in lysosomes via acid beta-glucosidase (glucocerebrosidase, GBA), which hydrolyzes GlcCer to ceramide and glucose. Deficiency of GBA causes accumulation of glucosylceramide in lysosomes and underlies Gaucher disease; accumulation can cause splenomegaly, bone lesions, and other symptoms. The term glucocerebroside in humans is commonly used interchangeably with glucosylceramide.

Functions of GlcCer include participation in membrane microdomains, mediating cell–cell interactions, and acting as a substrate for the biosynthesis of larger glycosphingolipids that contribute to blood group antigens and receptor functions. Dietary or plant-derived GlcCer is studied for potential effects on gut biology and lipid raft composition, but clinical significance remains under investigation.